A 40 kDa inhibitor of protein kinase C purified from bovine brain  by Hucho, Ferdinand et al.
Volume 211, number 2, 207-210 FEB 04386 January 1987 
A 40 kDa inhibitor of protein kinase C purified from bovine 
brain 
Ferdinand Hucho, Helmut Kriiger, Iris Pribilla and Ulrich Oberdieck 
Institut fir Biochemie, Freie Universitiit Berlin, Thielallee 63, 1000 Berlin 33, Germany 
Received 2 1 November 1986 
An inhibitor of protein kinase C has been purified to homogeneity from bovine brain cytosol by a four-step 
method. It is heat stable, has an apparent molecular mass of 40 kDa and is composed of two polypeptide 
chains of 19 kDa. 
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1. INTRODUCTION 
Protein kinase C (PKC) is one of the protein 
kinases involved in signal transduction from ex- 
tracellular space to intracellular targets [ 11. Besides 
Ca2+, diacylglycerol and phosphatidylserine, a 
variety of natural [2,3] and artificial [4] activators 
of PKC have been described. Little is known about 
inhibition of this enzyme: a synthetic inhibitor has 
been reported (R59002 [S]), and two reports of en- 
dogenous brain proteins affecting PKC activity ap- 
peared: Schwantke and Le Peuch [6] described a 
heat-labile inhibitory fraction which was not fur- 
ther purified or characterised. In particular, the 
presence of protein phosphatases counteracting 
histone phosphorylation by PKC was not exclud- 
ed. Protein phosphatases would mimic inhibition 
of protein phosphorylation. Calmodulin, S-100, 
and troponin C have also been shown to inhibit 
protein kinase C to various extents [7]. 
More recently McDonald and Walsh [8] detected 
several Ca’+-binding proteins in bovine brain, one 
of which, a heat-stabile Ca’+-binding protein of 
17 kDa inhibited PKC. Here we describe a PKC in- 
Correspondence address: F. Hucho, Institut fur 
Biochemie, Freie Universitlt Berlin, Thielallee 63, 1000 
Berlin 33, Germany 
hibitor which is similar in some and different in 
other aspects. In analogy to the inhibitor of the 
CAMP-dependent protein kinase it may be in- 
volved together with protein phosphatases in the 
regulation of target proteins of PKC. 
2. MATERIALS AND METHODS 
2.1. Partial purification of protein kinase C from 
bovine corpus striatum 
The procedure is a modification of a published 
purification of protein kinase C from whole rat 
brain [9]. Bovine striatum was homogenized in 
10 vols of a buffer containing 20 mM 
triethanolamine (TEA), pH 7.4, 0.3 M sucrose, 
10 mM EGTA, 2 mM EDTA, 5 mM dithio- 
erythritol (DTE), and the protease inhibitor 
phenylmethylsulfonyl fluoride (PMSF, 2 mM). 
Homogenization was accomplished by 20 strokes 
(1000 rpm) in a type S teflon homogenizer. The 
homogenate was centrifuged for 1 h at 100000 x g. 
The supernatant of this centrifugation was loaded 
on a column filled with the ion-exchange resin 
Whatman DE 52 equilibrated with 20 mM TEA, 
2 mM DTE, 10 mM EGTA and 2 mM EDTA. 
Subsequently the column was washed with 20 mM 
TEA, pH 7.4, containing 50 mM mercap- 
toethanol, 1 mM EGTA and 1 mM EDTA. Elu- 
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tion was performed with a O-150 mM NaCl 
gradient in washing buffer. All manipulations were 
performed at 4°C. Enzyme activity was assayed ac- 
cording to Roskowski [lo]. Protein was deter- 
mined as described by Bradford [l 11. 
2.2. Materials 
Histone (type III S), L-a-phosphatidyl-L-serine 
and phorbol lZmyristate, 13-acetate were pur- 
chased from Sigma, and [Y-~~P]ATP from NEN. 
The FPLC apparatus and the Superose 12 HR 
lo/30 and Mono Q HR 515 columns were Phar- 
macia. DEAE-cellulose and P 81 ion-exchange 
chromatography paper were from Whatman. Con- 
centration of protein fractions was performed by 
ultrafiltration with an Amicon cell using the 
PM-10 filter type. All other reagents were of the 
highest purity commercially available. 
2.3. Protein kinase C inhibitor (PKC-I) 
PKC-I was assayed by adding 10 pg protein of a 
sample to the PKC assay mixture. Free calcium 
concentration was adjusted to lo-’ M with 
EDTA/CaClz buffers. Inhibitor activity was ex- 
pressed as percent inhibition of PKC. 
3. RESULTS AND DISCUSSION 
3.1. Purification of a protein kinase C inhibitor 
from bovine striatum 
After separating PKC from the soluble fraction 
of bovine striatum as described in section 2 the 
DE 52 ion-exchange column was washed with a 
solution of 500 mM NaCl in 20 mM TEA buffer, 
pH 7.4, containing 50 mM mercaptoethanol, 
1 mM EDTA and 1 mM EGTA. The pooled 
protein-containing fractions were heated for 
30 min at 100°C (boiling water bath) and subse- 
quently centrifuged for 20 min at 100000 x g. The 
supernatant was extensively dialysed against 
20 mM TEA buffer, pH 7.4, containing 1 mM 
EDTA and 1 mM EGTA, and concentrated about 
5-fold by pressure-filtration (Amicon PM-10 
filter). This sample containing PKC-I but no pro- 
tein phosphatase activity was further purified via 
FPLC chromatography using a Superose size- 
exclusion column (fig. 1). The inhibitory activity 
eluted as a single peak corresponding to a 
molecular mass of about 40 kDa. The inhibitory 
fractions from 7 Superose runs were pooled, con- 
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Fig. 1. Gel-permeation chromatography: FPLC 
chromatography on a Superose 12 column. (-) 
Protein, as determined by light absorption at 280 nm; 
(m) PKC inhibitor activity. Eluant: 20 mM Hepes, 
pH 7.5, 1 mM EDTA, 150 mM NaCl, degassed and 
filtered; flow rate 0.8 ml/min. 
centrated (Amicon PM lo), and dialysed against 
20 mM phosphate buffer, pH 7.5, containing 
1 mM EDTA, 1 mM EGTA. The concentrated 
sample was applied to an FPLC ion-exchange col- 
umn (Mono Q) and eluted with an NaCl gradient 
(O-800 mM, two slopes). The inhibitory activity 
again elutes as a single peak (fig.2). 
3.2. Characterization of PKC-I 
The peak fraction from the Mono Q run con- 
tained only one protein of 19 kDa, as judged from 
SDS-polyacrylamide gel electrophoresis (fig.3). 
Molecular mass determination with the native pro- 
tein on a carefully calibrated Superose column 
(fig.4) gave about twice this molecular mass 
(40 kDa), indicating that the PKC-I is a dimer of 
two similar polypeptide chains. Fig.5 shows the in- 
hibition of PKC by increasing concentrations of 
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Fig.2. Ion-exchange chromatography: FPLC chromatography on a Mono Q column. NaCl gradient (0.800 mM, two 
slopes). (- ) Protein, (m) PKC inhibitor activity. 
PKC-I. Strikingly, complete inhibition could not 
be obtained. Whether or not this hints at different 
PKC entities in our preparation remains to be 
determined. 
Fig.3. SDS-polyacrylamide gel electrophoresis. Lanes: 1, 
marker proteins; 2, crude soluble bovine brain fraction; 
3, heat-resistant proteins from the high-salt wash of the 
DEAE column; 4, marker proteins; 5, pure PKC 
inhibitor after FPLC-Mono Q, migrating with an 
apparent molecular mass of 19 kDa. 15% 
polyacrylamide Laemmli gel, Coomassie blue stained. 
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Fig.4. Molecular mass determination of native protein 
kinase C. FPLC-Superose column calibrated with BSA 
(68 kDa), ovalbumin (45 kDa), carboanhydrase 
(30 kDa), chymotrypsinogen (26 kDa), cytochrome c 
dimer (23 kDa), and myoglobin (18 kDa). The native 
PKC inhibitor elutes with an apparent molecular mass of 
40 kDa. The two minor low molecular mass components 
eluting from this column have no inhibitory activity. 
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Fig.5. Dependence of inhibition of protein kinase C on 
PKC-I concentration. 
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